Gemma Collins Weight Gain, Weight Loss, and the Drug That Changed Everything

Recently, Gemma Collins captured a moment on camera that is, in a sense, more illuminating than any before-and-after shot. She was at a Turkish restaurant with her fiancé, Rami, the kind where a basket of bread is delivered to the table before you’ve even unfolded your napkin. She claimed that for the majority of her adult life, that basket would have been emptied without hesitation—not out of greed, but rather from something more demanding and draining than that. The bread sat there this time. She examined it. She kept her hands off of it. “You have no idea how strange it was for me to sit there with the bread in front of me. Are you aware of how strange that is? The audience chuckled. However, if you were paying attention, you could see something truly poignant beneath that: a woman explaining, in the simplest of terms, what it was like to feel free at last.

Since joining the original cast of TOWIE in 2011, Gemma Collins has become one of the most recognisable figures on British television, and her relationship with her body has been public knowledge for nearly as long. For more than ten years, Gemma Collins’ weight gain story has followed her through magazine covers, tabloid headlines, and TV appearances. She has talked about it, laughed about it, resisted it, and sometimes appeared to bear the burden of it, both literally and figuratively, in ways that the headline writers failed to recognise. Size has always been the simple version of this tale. The more truthful version discusses the true cost of living in a body that the public has chosen to continuously criticise.

Gemma Collins

Mounjaro, a prescription tirzepatide injection used to treat type 2 diabetes and manage weight, marked the beginning of the change. After being prescribed it, Gemma lost eight kilograms before having to stop due to a gallbladder attack. Gallbladder problems associated with fast weight loss or GLP-1 type medications are a common complication, but they are often overlooked in the more celebratory coverage of these drugs. She came to a halt. She got better. She reportedly resumed the treatment after that and lost a total of 3.5 stones. Twenty-two kilograms. Redistributed back into the world, it is comparable to a substantial child.

She is clearly different from Gemma Collins, who made headlines in 2014 when she left the original jungle series after just 72 hours, as she is now 45 and participating in I’m A Celebrity All Stars in South Africa. Though it’s important to keep in mind that she was dealing with health issues at the time and that the tendency to frame a sick person’s decision to leave as comedic material says more about the audience than the subject, that earlier exit has become one of those television moments that people trot out as a punchline. In contrast to her earlier public appearances, the version of Gemma Collins sitting around the campfire in 2026 and discussing bread baskets and body confidence with other celebrities seems genuinely at ease with herself.

As the media coverage of Gemma’s weight loss journey grows, it seems as though she stands for something greater than her own tale. The proliferation of GLP-1 medications, such as Mounjaro, Ozempic, and Wegovy, has given rise to a completely new category of celebrity health disclosure in which the traditional guidelines regarding what should be disclosed in public and what should be kept private are being rewritten in real time. Gemma has been remarkably open about the details, including the name of the medication, the side effects associated with the dosage, the gallbladder scare, and the choice to proceed. Given that she has built a career on transparency, it is plausible that her candour is strategic. It might also just be a reflection of what happens when someone decides to take charge of the story after fifteen years of having their body discussed without their permission.

She frequently uses the term “food noise” to describe the incessant, background hum of eating thoughts that, according to her, disappeared once she began the injections. It is a remarkably accurate depiction of something that millions of people encounter but seldom express with such clarity. She said to the Mirror, “I’m not thinking about food all the time.” “I feel so much better and free as a person to concentrate on other stuff.” It’s still unclear if Mounjaro is a long-term fix, a stopgap measure, or something she will have to deal with permanently. At the population level, the medical community is just starting to address these issues.

What is evident is that the story of Gemma Collins’ weight gain and weight loss has reached a point where it feels genuinely different from the previous chapters. It is quieter in certain aspects, more grounded, less motivated by outside pressure, and more driven by what appears to be a deliberate personal decision, at least from the outside. The bread basket remained full. She claims to have felt free. That’s enough of a story for now.